Biological responses to administered interferon in alcoholics

Area of Science:

• Immunology
• Hepatology
• Pharmacology

Background:

• Chronic alcohol consumption is prevalent and impacts immune function.
• Interferon (IFN) therapy is used for various diseases, but its efficacy can be influenced by patient factors.
• Understanding alcohol's effect on IFN response is critical for optimizing treatment.

Purpose of the Study:

• To investigate how chronic alcohol intake affects the physiological response to natural human interferon-alpha (nHuIFN-alpha Ly) therapy.
• To compare IFN response markers between alcoholics, nonalcoholic chronic hepatitis C (CH-C) patients, and healthy controls.

Main Methods:

• Administered 3 million units of nHuIFN-alpha Ly to alcoholics, CH-C patients, and healthy subjects.
• Monitored serum 2'-5' oligoadenylate synthetase activity, beta 2-microglobulin, C-reactive protein (CRP), and body temperature serially.
• Compared changes in these markers post-IFN administration across the groups.

Main Results:

• Alcoholics showed significantly lower increases in 2'-5' oligoadenylate synthetase activity, CRP response, and body temperature after IFN administration compared to CH-C patients and controls.
• Pre-treatment serum beta 2-microglobulin levels were elevated in alcoholics compared to the other groups.
• These findings indicate a generally decreased physiological response to exogenous IFN in alcoholics.

Conclusions:

• Chronic alcohol intake impairs the body's physiological response to interferon therapy.
• Patient alcohol consumption status is a significant factor influencing IFN treatment efficacy.
• Recommendations include alcohol abstinence and careful consideration of IFN therapy initiation timing for maximizing treatment benefits.